These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3377460

  • 21. Comparison of cefonicid and cefamandole for the treatment of community-acquired infections of the lower respiratory tract.
    Geckler RW, McCormack GD, Goodman JS.
    Rev Infect Dis; 1984; 6 Suppl 4():S847-52. PubMed ID: 6395275
    [Abstract] [Full Text] [Related]

  • 22. Cefonicid concentration in lung tissue after intramuscular administration.
    Cruciani M, Savio S, Concia E.
    Int J Clin Pharmacol Res; 1987; 7(6):481-4. PubMed ID: 3440639
    [Abstract] [Full Text] [Related]

  • 23. Comparison of cefonicid and cefazolin for treatment of soft-tissue infections.
    Slutkin G, Marzouk J, Dall L, Mills J.
    Rev Infect Dis; 1984; 6 Suppl 4():S853-6. PubMed ID: 6395276
    [Abstract] [Full Text] [Related]

  • 24. Cefonicid concentrations in serum and atrial tissue during open-heart surgery.
    Sterling RP, Connor DJ, Norman JC, Cooley DA.
    Antimicrob Agents Chemother; 1983 May; 23(5):790-2. PubMed ID: 6870226
    [Abstract] [Full Text] [Related]

  • 25. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
    Mini E, Mazzei T, Periti P, Reali EF, Bordonaro P, Balocchini E, Ninu B.
    Chemioterapia; 1987 Apr; 6(2):95-8. PubMed ID: 3594635
    [Abstract] [Full Text] [Related]

  • 26. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
    Mini E, Mazzei T, Periti P, Reali EF, Bordonaro P, Balocchini E, Ninu B.
    Chemioterapia; 1987 Jun; 6(2 Suppl):243-6. PubMed ID: 3509398
    [No Abstract] [Full Text] [Related]

  • 27. Bioavailability in human volunteers of three intramuscular formulations of cefonicid: a long-acting cephalosporin.
    Brumfitt W, James I, Hamilton-Miller JM, Grady D, Price C.
    Biopharm Drug Dispos; 1988 Jun; 9(3):251-7. PubMed ID: 3395666
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Review of cefonicid, a long-acting cephalosporin.
    Dudley MN, Quintiliani R, Nightingale CH.
    Clin Pharm; 1984 Jun; 3(1):23-32. PubMed ID: 6365414
    [Abstract] [Full Text] [Related]

  • 30. Stability of cefonicid sodium in infusion fluids.
    Wong WW, Maderich AB, Polli GP, Ravin LJ.
    Am J Hosp Pharm; 1985 Sep; 42(9):1980-3. PubMed ID: 4050816
    [Abstract] [Full Text] [Related]

  • 31. Cefonicid: an overview of clinical studies in the United States.
    Jacob LS, Layne P.
    Rev Infect Dis; 1984 Sep; 6 Suppl 4():S791-802. PubMed ID: 6395272
    [Abstract] [Full Text] [Related]

  • 32. Kinetics and renal handling of cefonicid.
    Pitkin D, Dubb J, Actor P, Alexander F, Ehrlich S, Familiar R, Stote R.
    Clin Pharmacol Ther; 1981 Nov; 30(5):587-93. PubMed ID: 7297018
    [Abstract] [Full Text] [Related]

  • 33. Cefonicid concentrations in human aqueous humor.
    Axelrod JL, Kochman RS.
    Arch Ophthalmol; 1984 Mar; 102(3):433-4. PubMed ID: 6608343
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The effects of cefonicid on the pharmacokinetics of a once-a-day theophylline formulation.
    Cazzola M, Lobefalo G, Lupis F, Vanacore L, Martucci P, D'Amato G.
    Int J Clin Pharmacol Res; 1989 Mar; 9(3):169-73. PubMed ID: 2663736
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Treatment of urinary tract infections in hospitalized patients: a double-blind comparison of cefonicid and cefamandole.
    Cox CE, Jacob LS.
    Rev Infect Dis; 1984 Mar; 6 Suppl 4():S839-43. PubMed ID: 6395273
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of cefepime in patients with respiratory tract infections.
    Kovarik JM, ter Maaten JC, Rademaker CM, Deenstra M, Hoepelman IM, Hart HC, Matzke GR, Verhoef J.
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1885-8. PubMed ID: 2291655
    [Abstract] [Full Text] [Related]

  • 39. Randomized, double-blind trial of cefonicid and nafcillin in the treatment of skin and skin structure infections.
    Daly JS, Worthington MG, Andrews RJ, Brown RB, Schwartz R, Sexton DJ.
    Antimicrob Agents Chemother; 1990 Apr; 34(4):654-6. PubMed ID: 2344171
    [Abstract] [Full Text] [Related]

  • 40. An overview: evaluation of cefonicid in infections of the urinary tract, lower respiratory tract, and skin and soft tissue.
    Kaye D.
    Rev Infect Dis; 1984 Apr; 6 Suppl 4():S835-8. PubMed ID: 6522926
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.